Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment
Clinical trial NCT00237198 · COMPLETED
Trial details
- NCT number
- NCT00237198
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2006-07-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.